Lucid Diagnostics Inc. Adjustments to Additional Paid in Capital, Other
Lucid Diagnostics Inc. (LUCD) reported Adjustments to Additional Paid in Capital, Other of $17.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-11-12
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for the quarter ending 2025-09-30 was $17.00K, a 60.47% decline year-over-year.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for the quarter ending 2025-06-30 was $1.00K, a 98.95% decline year-over-year.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $81.00K, a 57.14% decline year-over-year.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for the quarter ending 2024-12-31 was $22.00K, a 89.77% decline year-over-year.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for fiscal 2024 was $351.00K, a 66.89% decline from fiscal 2023.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for fiscal 2023 was $1.06M, a 6.36% decline from fiscal 2022.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for fiscal 2022 was $1.13M, a 143.44% increase from fiscal 2021.
- Lucid Diagnostics Inc. adjustments to additional paid in capital, other for fiscal 2021 was $465.00K, a 3476.92% increase from fiscal 2020.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 3 month as first filed | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 9 month as first filed | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|---|---|
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-12 | $18.00K derived: sum of 2 quarters · filed 2025-11-12 | $99.00K 10-Q · filed 2025-11-12 | $121.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-12 | $82.00K 10-Q · filed 2025-08-12 | $104.00K derived: sum of 3 quarters · filed 2025-08-12 | $147.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2025-03-31 | $81.00K 10-Q · filed 2025-05-13 | $103.00K derived: sum of 2 quarters · filed 2025-05-13 | $146.00K derived: sum of 3 quarters · filed 2025-11-12 | $241.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $65.00K derived: sum of 2 quarters · filed 2025-11-12 | $160.00K derived: sum of 3 quarters · filed 2025-11-12 | $351.00K 10-K · filed 2025-03-24 | ||
| 2024-09-30 | $43.00K 10-Q · filed 2025-11-12 | $138.00K derived: sum of 2 quarters · filed 2025-11-12 | $329.00K 10-Q · filed 2025-11-12 | $542.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $95.00K 10-Q · filed 2025-08-12 | $285.00K 10-Q · filed 2025-08-12 | $499.00K derived: sum of 3 quarters · filed 2025-08-12 | $719.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $189.00K 10-Q · filed 2025-05-13 | $404.00K derived: sum of 2 quarters · filed 2025-05-13 | $624.00K derived: sum of 3 quarters · filed 2025-05-13 | $858.00K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $435.00K derived: sum of 2 quarters · filed 2025-03-24 | $669.00K derived: sum of 3 quarters · filed 2025-03-24 | $1.06M 10-K · filed 2025-03-24 | ||
| 2023-09-30 | $220.00K 10-Q · filed 2024-11-12 | $454.00K derived: sum of 2 quarters · filed 2024-11-12 | $845.00K 10-Q · filed 2024-11-12 | $1.10M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $234.00K 10-Q · filed 2024-08-12 | $625.00K 10-Q · filed 2024-08-12 | $877.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.17M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $391.00K 10-Q · filed 2024-05-13 | $643.00K derived: sum of 2 quarters · filed 2024-05-13 | $934.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.22M derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $543.00K derived: sum of 2 quarters · filed 2024-03-25 | $833.00K derived: sum of 3 quarters · filed 2024-03-25 | $1.13M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $291.00K 10-Q · filed 2023-11-13 | $581.00K derived: sum of 2 quarters · filed 2023-11-13 | $880.00K 10-Q · filed 2023-11-13 | $1.23M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $290.00K 10-Q · filed 2023-08-14 | $588.00K 10-Q · filed 2023-08-14 | $942.00K derived: sum of 3 quarters · filed 2023-08-14 | $998.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $298.00K 10-Q · filed 2023-05-15 | $652.00K derived: sum of 2 quarters · filed 2023-05-15 | $708.00K derived: sum of 3 quarters · filed 2023-05-15 | $761.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $410.00K derived: sum of 2 quarters · filed 2023-03-14 | $463.00K derived: sum of 3 quarters · filed 2023-03-14 | $465.00K 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $56.00K 10-Q · filed 2022-11-14 | $55.45K 10-Q · filed 2021-11-23 | $109.00K derived: sum of 2 quarters · filed 2022-11-14 | $111.00K 10-Q · filed 2022-11-14 | $111.08K 10-Q · filed 2021-11-23 | $115.25K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $53.00K 10-Q · filed 2022-08-15 | $56.00K 10-Q · filed 2022-08-15 | $59.25K derived: sum of 3 quarters · filed 2022-08-15 | $62.50K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-16 | $6.25K derived: sum of 2 quarters · filed 2022-05-16 | $9.50K derived: sum of 3 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $3.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $6.50K derived: sum of 2 quarters · filed 2022-04-06 | $13.00K 10-K · filed 2022-04-06 | |||
| 2020-09-30 | $3.25K 10-Q · filed 2021-11-23 | $9.75K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |